Insider and Institutional Ownership
56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 12.0% of INVO Bioscience shares are held by institutional investors. 5.2% of Acutus Medical shares are held by company insiders. Comparatively, 3.5% of INVO Bioscience shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Valuation and Earnings
This table compares Acutus Medical and INVO Bioscience”s gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Acutus Medical | $7.16 million | 0.02 | -$81.66 million | N/A | N/A |
INVO Bioscience | $5.77 million | 0.66 | -$8.03 million | N/A | N/A |
Risk and Volatility
Acutus Medical has a beta of -0.35, suggesting that its share price is 135% less volatile than the S&P 500. Comparatively, INVO Bioscience has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500.
Profitability
This table compares Acutus Medical and INVO Bioscience’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Acutus Medical | -272.74% | -311.64% | -11.57% |
INVO Bioscience | -122.79% | N/A | -36.94% |
Summary
INVO Bioscience beats Acutus Medical on 5 of the 9 factors compared between the two stocks.
About Acutus Medical
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
About INVO Bioscience
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.
Receive News & Ratings for Acutus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acutus Medical and related companies with MarketBeat.com's FREE daily email newsletter.